UHS

Business Context and Reporting Period

Company: Universal Health Services, Inc. (UHS)
Filing Type: Form 10-Q (Unaudited)
Reporting Period: Three months ended March 31, 2026
Overview: UHS operates 375 inpatient facilities and 168 outpatient facilities across 40 U.S. states, Washington D.C., the U.K., and Puerto Rico. The company operates through two reportable segments: Acute Care Hospital Services and Behavioral Health Care Services.

Key Financial Metrics

Margins: Operating margin was 11.2% in Q1 2026 compared to 11.1% in Q1 2025. The effective income tax rate was 23.5% for both periods.

Material Changes vs. Prior Period

• Revenue Growth: Net revenues increased 9.6% ($395 million) year-over-year. This was driven by a 7.9% increase in "Same Facility" revenues and $34 million from new facilities, including the newly opened Cedar Hill Regional Medical Center in Washington, D.C.
• Profitability: Net income attributable to UHS increased 10% ($32 million). Income before taxes rose 12% to $469 million.
• Segment Performance:
  • Acute Care: Same facility revenues increased 8.2%. Income before taxes increased 14% on a same-facility basis.
  • Behavioral Health: Same facility revenues increased 7.3%. Income before taxes increased 8% on a same-facility basis.
• Costs: Salaries, wages, and benefits increased 7% year-over-year. Other operating expenses increased 16%, partly due to increased provider tax assessments and costs at new facilities.
• Capital Allocation: The company repurchased $127.3 million of Class B Common Stock and paid $13.0 million in dividends ($0.20 per share).

Guidance, Outlook, and Risks

Outlook and Capital Expenditures

UHS expects full-year 2026 capital expenditures to range between $950 million and $1.1 billion. Approximately $217 million was spent in Q1 2026, with the remainder expected to be spent in the rest of the year.

Acquisition Activity

On March 9, 2026, UHS announced a definitive agreement to acquire Talkspace, Inc. for approximately $835 million. The transaction is expected to close in Q3 2026 and will be financed through additional borrowings under the company's credit agreement.

Debt and Liquidity

In April 2026 (post-period end), UHS amended its credit agreement to increase borrowing capacity by $900 million, including a new $400 million delayed draw term loan intended to fund the Talkspace acquisition. The company has $700 million in senior notes maturing in September 2026, which it expects to refinance at higher interest rates.

Key Risks and Contingencies

• Legislative Impact (OBBBA): The "One Big Beautiful Bill Act" enacted in July 2025 imposes work requirements for Medicaid and limits provider taxes. UHS estimates this will reduce aggregate annual net benefit from Medicaid supplemental payments by approximately $432 million to $480 million by 2032.
• Legal Proceedings:
  • Cumberland Litigation: A jury awarded $60 million in compensatory damages and $180 million in trebled damages (plus punitive damages) against a subsidiary regarding allegations of sexual misconduct. Punitive damages were reduced to $1.05 million by the court. Approximately 43 additional plaintiffs remain pending. The company estimates remaining insurance coverage for the 2020 policy year is approximately $143 million.
  • Pinnacle Litigation: A verdict was rendered against a subsidiary for $4.7 million in compensatory damages and $500 million in punitive damages (expected to be reduced to ~$14 million). A motion for a new trial was granted in March 2026.
• Medicaid Certification: Laurel Ridge Treatment Center in Texas was terminated from the Medicare/Medicaid program in April 2026. The facility is appealing and expects to incur operating losses during the reapplication process.

Investor Verification Checklist

• Medicaid Revenue Exposure: Verify the specific impact of the "One Big Beautiful Bill Act" on state-specific supplemental payment programs (Texas, Nevada, etc.) and the timeline for revenue reductions.
• Legal Reserves: Confirm the adequacy of reserves for the Cumberland and Pinnacle litigation outcomes, particularly regarding the potential exhaustion of insurance coverage and the outcome of the new trial motion in the Pinnacle case.
• Debt Refinancing: Assess the cost of refinancing the $700 million 2026 Notes maturing in September 2026 given current interest rate environments.
• Acquisition Integration: Monitor the regulatory approval status and integration risks associated with the $835 million Talkspace acquisition.
• Laurel Ridge Status: Track the progress of the Medicare/Medicaid recertification for Laurel Ridge Treatment Center and the associated cash flow impact.